The joint venture between Biogen (NASDAQ: BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI ®, an etanercept biosimilar referencing Enbrel ® ...

The first biosimilar version of Pfizer/Amgen’s multi-billion-dollar anti-inflammatory Enbrel (etancerpt) has now been launched in the UK, offering access to a cheaper alternative that could drive down ...

Biogen (BIIB) today announced further progress as part of its commitment to biosimilars. Samsung Bioepis, the joint venture between Samsung Biologics and Biogen, has received a positive opinion from ...

ZUG, Switzerland--(BUSINESS WIRE)--Real world evidence from investigator-initiated studies supported by Biogen (NASDAQ: BIIB), demonstrating sustained efficacy and safety, and high acceptance and ...

ZUG, Switzerland--(BUSINESS WIRE)--The joint venture between Biogen (NASDAQ:BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced real-world data of BENEPALI™ in patients with moderate to severe psoriasis from the British Association of Dermatologists ...

Shares of Biogen Inc (NASDAQ: BIIB) were trading higher by 2 percent at $279.00 early Tuesday morning after the company announced that the European Union has granted marketing authorization for its ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive ...

Ÿ In just under four years, Samsung Bioepis develops, tests and receives regulatory approval for Benepali®, the first etanercept biosimilar in the European Union Ÿ The European Commission approval ...

Samsung Bioepis has announced real-world data from the drug. Samsung Bioepis has announced real-world data from an observational study of Benepali (etanercept), in patients with moderate to severe ...

The White House on Saturday released details about the agreement that U.S. President Donald Trump reached this week with Chinese President Xi Jinping to de-escalate their countries’ trade war, ...

BENEPALI, as the first etanercept biosimilar referencing Enbrel approved in the EU, can help expand access to treatment options for people affected by chronic inflammatory conditions.” The EC approval ...